ferrexpo secures $15m loan from largest shareholder

Ferrexpo secured a $15 million unsecured, subordinated 12-month loan from its largest shareholder, Fevamotinico, at 9.75% interest to provide immediate liquidity and fund working capital and resumed production. The facility is an advance against Fevamotinico's roughly $40 million subscription in Ferrexpo's planned approximately $100 million fundraising. The financing underscores near-term liquidity needs, while completion remains contingent on shareholder approval at the September 21 general meeting and the placing agreement remaining in force.

Analysis

FXPO's equity is now principally a financing-completion option rather than a pure iron-ore or production-restart exposure. The bridge facility reduces near-term operational interruption risk, but it also underscores that internally generated liquidity remains insufficient to fund working capital through the ramp. The 9.75% coupon is less important than the embedded dilution: if shareholder approval or placing execution fails, the controlling shareholder has a route to convert a senior liquidity claim into equity at the fundraising price, likely creating a practical ceiling on the shares until admission is complete.

The restrictive debt covenant is a second-order negative. It limits management's flexibility to raise asset-backed, trade-finance, or secured working-capital funding if the operating restart consumes more cash than planned; this increases dependence on the controlling shareholder and makes minority holders structurally subordinate in future negotiations. Production normalization over the next 1-3 months is therefore not sufficient to de-risk the stock unless management demonstrates positive operating cash conversion and receivables/inventory discipline.

Consensus may over-credit the shareholder support as a clean positive. A near-50% owner has strong incentive to preserve enterprise value, but its financing also consolidates control at precisely the point minority shareholders face dilution and limited alternative-capital options. The upside case requires successful fundraising, uninterrupted logistics, and a ramp that avoids another liquidity request; absent these, equity value can compress disproportionately because the company has little visible balance-sheet optionality.

Key Decisions for Investors

• Remain neutral/avoid new FXPO longs ahead of the shareholder vote and fundraising admission; treat completion as a binary catalyst rather than buying the production-restart narrative. Reassess only after final share count, issue price, and net cash proceeds establish the dilution-adjusted equity value.
• For existing FXPO holders, reduce exposure into any liquidity-relief rally unless the shares trade at a material discount to the announced subscription price and management provides a quantified working-capital runway through the next operating quarter.
• Set a 1-3 month monitoring trigger: initiate a tactical long only if fundraising completes, production remains uninterrupted for at least one reporting cycle, and no incremental related-party financing or covenant amendment is required. Falsification is any further bridge funding, delayed admission, or guidance implying negative cash generation beyond the current ramp.
• Do not use leverage or short-dated options around the vote: downside is driven by dilution, liquidity, and Ukraine-specific operating risk, while available public information does not provide a reliable probability-weighted valuation for a tight stop-loss framework.